The
Section on Hormonal Regulation performs research on the mechanisms by which
peptide hormones control the activities of endocrine and other target cells.
Areas of interest include the characterization of receptors, signal transduction
pathways, and other cellular processes involved in the neural control of
gonadotropin-releasing hormone (GnRH) biosynthesis and secretion, the regulation
and structure-function properties of receptors for GnRH and angiotensin
II (Ang II), and the actions of GnRH and Ang II on target cells in the hypothalamus,
pituitary, and adrenal glands. Current research concerns the structural
features and signal transduction mechanisms on the GnRH and Ang II receptors
and the manner in which these mechanisms regulate the secretory and growth
responses of hypothalamic, pituitary, and adrenal cells.
Structure/Function Properties of the GnRH Receptor
Chung, Arora, Catt
The GnRH receptor is a unique tail-less member of the G protein-coupled
receptor (GPCR) family. It signals primarily through the phosphoinositide/calcium
pathway and activation of MAP kinases to promote secretory and growth
responses. The GnRH receptor is coupled to Gq/11
via its second and third intracellular loops and to Gs via its first loop.
The agonist-induced coupling of heptahelical receptors to their cognate
G proteins often depends on the amino-terminal region of the third intracellular
loop. Many GPCRs, including the GnRH and AT1 receptors, contain an apolar
amino acid in this region at a constant distance from conserved Pro and
Tyr/Asn residues in the fifth transmembrane domain. In the GnRH and angiotensin
AT1 receptors, the residue (Leu237) is an important determinant of receptor
expression and function. It is part of a conserved N/YxxIxxxL motif that
is often present in the third intracellular loop of GPCRs and is likely
to be of general importance in their expression, agonist-induced activation,
coupling to cognate G proteins, and internalization.
The GnRH Pulse Generator
Krsmanovic, Martinez-Fuentes, Arora, Mores, and Chen in collaboration
with Stojilkovic (SCS, ERRB)
The pulsatile secretory activity of GnRH-producing neurons in the hypothalamus,
and consequently of pituitary gonadotroph cells, is essential for the
maintenance of normal patterns of gonadotropin secretion and reproductive
function. The process can be analyzed in vitro because the pulsatile release
of GnRH also occurs in cultured fetal hypothalamic cells and immortalized
GnRH neurons (GT1-7 cells). Both native and transformed GnRH neurons express
GnRH receptors that mediate agonist- and antagonist-induced changes in
episodic secretory activity. Studies on both hypothalamic cells and GT1-7
cells have shown that the feedback actions of GnRH on its receptors in
the GnRH neuron are involved in the genesis of pulsatile neuropeptide
secretion. Blockade of neuronal GnRH receptors by specific antagonists
abolishes pulsatile secretion and causes a slowly progressive increase
in GnRH release. These and other observations are consistent with the
existence and function of autocrine regulation of the GnRH neuron by its
neuropeptide product. Pituitary gonadotrophs also release GnRH as well
as LH, and treatment with a GnRH receptor antagonist or GnRH antiserum
reduces basal LH release. The presence and actions of GnRH in the anterior
pituitary gland suggest that local regulatory effects of the neuropeptide
could supplement the primary hypothalamic mechanism for the control of
episodic gonadotropin secretion. In the hypothalamus, the regulatory actions
of GnRH on cyclic AMP and calcium signaling, together with the ultrashort
loop feedback effects of GnRH on its cells of origin, exert both positive
and negative actions on neuropeptide release that serve to maintain the
episodic mode of GnRH secretion.
Regulation of Calcium-Sensitive Adenylyl Cyclase in GnRH Neurons
Krsmanovic, Mores, Navarro, Tomic, Catt
GnRH production and secretion depend on both calcium and cyclic AMP levels
in hypothalamic GnRH neurons. Studies on intracellular signaling in immortalized
GnRH neurons revealed that cAMP production is elevated by increased extracellular
Ca2+ and the Ca2+
channel agonist, BK-8644, and is diminished by low extracellular Ca2+
and treatment with nifedipine. These findings are consistent with the
abundant expression of adenylyl cyclase type I (type I AC) in GnRH neurons.
Potassium-induced depolarization of GT1-7 neurons causes a dose-dependent
monotonic increase in [Ca2+]i and elicits
a bell-shaped cAMP response. The inhibitory phase of the cAMP response
is prevented by pertussis toxin (PTX), consistent with the activation
of Gi-related proteins during depolarization. Agonist activation of the
endogenous GnRH receptor in GT1-7 neurons also elicits a bell-shaped change
in cAMP production. The inhibitory action of high GnRH concentrations
is prevented by PTX, indicating coupling of the GnRH receptors to Gi-related
proteins at high levels of agonist activation. The stimulation of cAMP
production by activation of endogenous luteinizing hormone receptors in
GT1-7 cells is enhanced by low (nanomolar) concentrations of GnRH but
is abolished by micromolar concentrations of GnRH, again in a PTX-sensitive
manner. These findings indicate that GnRH neuronal cAMP production is
maintained by Ca2+ entry through voltage-sensitive
calcium channels, leading to activation of Ca2+-stimulated
type I AC. Furthermore, the Ca2+ influx-dependent
activation of AC I operates in conjunction with AC regulatory G proteins
to determine basal and agonist-stimulated levels of cAMP production in
the GnRH neuron.
Regulatory Actions of Estrogen Receptors in GnRH Neurons
Navarro, Krsmanovic, Catt
We observed an interaction between estrogen receptors and intracellular
signaling in hypothalamic GnRH neurons and their immortalized counterparts
(GT1-7 cells), both of which express estrogen (ERa
and ERb) and progesterone receptors.
Both cell types exhibited positive immunostaining for plasma membrane
ERs as well as estradiol-induced changes in adenylyl cyclase activity.
In GT1-7 cells, short-term treatment (five minutes) with estradiol caused
dose-dependent inhibition of cAMP production. More prolonged treatment
(60 minutes) with picomolar estradiol concentrations inhibited, while
nanomolar concentrations increased, cAMP production. The ER antagonist
ICI 182,780 abolished both inhibitory and stimulatory actions of estradiol
on cAMP production. Estradiol-induced inhibition of adenylyl cyclase was
also prevented by treatment with pertussis toxin, consistent with coupling
of the membrane-bound estradiol receptors to an inhibitory G protein.
Inhibitory actions of estradiol on adenylyl cyclase were also evident
in membrane fractions and in cells treated with estrogen-protein conjugates.
In perifused GT1-7 cells and hypothalamic neurons, treatment with ovulatory
phase estradiol levels increased the GnRH peak interval, shortened peak
duration, and increased peak amplitude. These findings have demonstrated
that membrane-associated ER expressed in GnRH neurons interact with adenylyl
cyclase inhibitory G proteins by a rapid nongenomic mechanism and modulate
intracellular cAMP signaling and neuropeptide secretion.
Angiotensin Receptor Structure, Activation, and Phosphorylation
Hunyady, Olivares-Reyes, Smith, Catt
The goal of the project is to elucidate the molecular mechanisms of receptor
activation and intracellular signaling that are initiated by the pressor
octapeptide, angiotensin II (Ang II). Most of the diverse physiological
actions of Ang II in cardiovascular, renal, neuronal, and other target
cells are mediated by the Gq/11 protein-coupled AT1 receptor. In general,
the functions of the distantly related AT2 receptor counteract the growth-related
actions of the AT1 receptor. The third intracellular loop of the AT1 receptor
and other GPCRs is an important determinant of G protein coupling. We
previously identified four specific amino acids that are required for
Gq/11 coupling to this domain of the AT1 receptor and probably to other
GPCRs. They are the Tyr215 and Leu223 residues in the N-terminal region
of the third intracellular loop and Ile238 and Phe239 in the N-terminal
region. Agonist activation is accompanied by rapid phosphorylation of
the AT1 receptor at several serine/threonine residues in its C-terminal
intracellular tail and by sequestration of the agonist-receptor complex
via a beta-arrestin- and clathrin-dependent endocytic mechanism. In contrast,
the angiotensin AT2 receptor, which is coupled to activation of tyrosine
phosphatase and inhibition of MAPK kinase, is phosphorylated at a single
residue (Ser354) in its cytoplasmic tail and does not undergo agonist-induced
internalization. In addition to rapid phosphorylation via PKC during homologous
activation by Ang II, the AT2 receptor undergoes heterologous PKC-dependent
phosphorylation during activation by the AT1 receptor. This process could
contribute to activation of the counterregulatory action of AT2 receptors
on AT1 receptor-mediated growth responses.
Properties of a Phosphorylation-Deficient AT1 Receptor
Olivares-Reyes, Smith, Hunyady, Shah, Catt
In most GPCRs, agonist binding is rapidly followed by phosphorylation
of serine/threonine residues. It is predominantly mediated by specific
receptor kinases (GRKs) and depends on adjacent acidic residues located
in the C-terminal tail or the third intracellular loop of the receptor.
No such residues are present in the AT1 receptor tail, but an analysis
of the functional role of a diacidic motif (Asp236-Asp237) in its third
intracellular loop revealed that substitution of both amino acids with
alanine or asparagine residues diminished Ang II-induced AT1 receptor
phosphorylation in COS-7 cells. However, the ability of the phosphorylation-deficient
(DD-mutant) receptor to mediate Ang II-stimulated inositol phosphate production,
MAP-kinase activation, and AT1 receptor desensitization and internalization
was not significantly impaired. Overexpression of dominant negative GRK2(K220M)
decreased agonist-induced receptor phosphorylation by about 40 percent
but did not further reduce the impaired phosphorylation of the DD-mutant
receptors. Inhibition of PKC by bisindolylmaleimide reduced the phosphorylation
of both the wild-type and DD-mutant receptors by about 30 percent. The
inhibitory effects of GRK2(K220M) expression and PKC inhibition on agonist-induced
phosphorylation were additive for the wild-type AT1-R but not for the
DD-mutant receptors. Agonist-induced internalization of the wild-type
and DD-mutant receptors was similar and unaltered by coexpression of dominant
negative GRK2. These findings indicate that an acidic motif in the third
intracellular loop of the AT1-R is required for agonist-induced phosphorylation
of its carboxyl-terminal tail by GRKs. The properties of the DD-mutant
receptors suggest that Ang II-induced signaling as well as receptor desensitization
and internalization do not depend on GRK-mediated phosphorylation of the
agonist-activated AT1 receptor.
MAP Kinase Activation by the Angiotensin AT1 Receptor
Shah, Catt
The ability of several agonist-activated GPCRs to stimulate MAP-kinase
activity and growth responses is mediated by a variety of intracellular
pathways, including transactivation of growth factor receptors and their
downstream signaling cascades to the nucleus. Agonist activation of endogenous
AT1 receptors expressed in hepatic C9 cells markedly stimulates phosphoinositide
hydrolysis and activates PKCd; the activation also stimulates phosphorylation
of the proline-rich tyrosine kinase, Pyk-2, and activates ERK1/2. The
stimulatory actions of Ang II on Pyk2 and ERK phosphorylation were abolished
by PKC depletion and selective inhibition of PKCd by rottlerin, but not
by Ca2+ chelators. These effects, and the
similar actions of the Src kinase inhibition, implicate PKCd and Src kinase
in ERK activation. Phorbol myristyl acetate (PMA) caused much greater
phosphorylation of Pyk2 and ERK than ionomycin, and the effects of PMA
and Ang II were abolished in PKC-depleted cells. Ang II also increased
the association of Pyk2 with Src and with the EGF receptor (EGF-R). EGF
caused much greater tyrosine phosphorylation of the EGF-R than Ang II
and PMA. Ang II-induced activation of ERK but not of Pyk2 was prevented
by inhibition of EGF receptor phosphorylation by AG1478 and of Src kinase
by PP1. Ang II also increased the association of the adaptor protein,
Grb2, with the EGF-R. These findings indicate that Src and Pyk2 act upstream
of the EGF-R and that most of the Ang II-induced ERK phosphorylation depends
on transactivation of the EGF-R. In summary, Ang II-induced ERK activation
in C9 hepatic cells is initiated by a PKCd-dependent but Ca2+-independent
mechanism and is mediated by the Src/Pyk2 complex through transactivation
of the EGF-R.
|
PUBLICATIONS
- Catt
KJ, Olivares-Reyes AJ, Zhang M, Smith RD, Hunyady L. Activation
and phosphorylation of angiotensin AT1 and AT2 receptors. Endocr Res
2000;26:559-560.
- Gáborik
Z, Szaszák M, Szidonya L, Balla B, Paku S, Catt KJ, Clark AJL,
Hunyady L.b-arrestin- and dynamin-dependent
endocytosis of the AT1 angiotensin receptor. Mol Pharmacol 2001;59:239-247.
- García-Caballero
A, Olivares-Reyes JA, Catt KJ, García-Saínz JA. Angiotensin
AT1 receptor phosphorylation and desensitization in a hepatic cell line.
Roles of protein kinase C and phosphoinositide 3-kinase. Mol Pharmacol
2001;59:576-585.
- Krsmanovic
LZ, Mores N, Navarro CE, Tomic M, Catt KJ. Regulation of Ca2+-sensitive
adenylyl cyclase in gonadotropin-releasing hormone neurons. Mol Endocrinol
2001;15:429-440.
- Olivares-Reyes
JA, Jayadev S, Hunyady L, Catt KJ, Smith RD. Homologous and heterologous
phosphorylation of the AT2 angiotensin receptor by protein kinase C.
Mol Pharmacol 2000;58:1156-1161.
- Olivares-Reyes
JA, Smith RD, Hunyady L, Shah BH, Catt KJ. Agonist-induced signaling,
desensitization, and internalization of a phosphorylation-deficient
AT2 angiotensin receptor. J Biol Chem 2001;276:37761-37768.
- Shah
BH, Catt KJ. Calcium-independent activation of ERK1/2 MAP kinases
by angiotensin II in hepatic C9 cells: roles of PKCd, Src/Pyk2, and
EGF receptor transactivation. Mol Pharmacol, in press.
- Shah
BH, Olivares-Reyes AJ, Yesilkaya A, Catt KJ. Independence of angiotensin
II-induced MAP kinase activation from AT1-receptor
internalization in clone 9 hepatocytes. Mol Endocrinol, in press.
- Vacca
F, Bagnato A, Catt KJ, Tecce R. Transactivation of the epidermal
growth factor receptor in endothelin-1-induced mitogenic signaling in
human ovarian carcinoma cells. Cancer Res 2000;60:5310-5317.
|